Although we found no significant relationship between 18F-FDG uptake and KRAS mutation status in lung adenocarcinoma and did not identify any genes specifically correlated with glucose metabolism in KRAS m+ tumors, a conclusive answer to this question would require a larger sample size. Here, KRAS is linked to lung adenocarcinoma.